Remote Digital Technologies for the Early Detection and Monitoring of Cognitive Decline in Patients With Type 2 Diabetes: Insights From Studies of Neurodegenerative Diseases

被引:0
|
作者
DuBord, Ashley Y. [1 ,2 ]
Paolillo, Emily W. [1 ]
Staffaroni, Adam M. [1 ]
机构
[1] Univ Calif San Francisco, Weill Inst Neurosciences, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
[2] 2 Diabet Technol Soc, Burlingame, CA USA
来源
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2024年 / 18卷 / 06期
关键词
type; 2; diabetes; Alzheimer's disease; mild cognitive impairment; cognitive decline; digital biomarkers; health technology; ALZHEIMERS-DISEASE; AUTOMATIC DETECTION; OLDER-ADULTS; IMPAIRMENT; DEMENTIA; MELLITUS; BATTERY; INSULIN; RECOGNITION; PERFORMANCE;
D O I
10.1177/19322968231171399
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a risk factor for cognitive decline. In neurodegenerative disease research, remote digital cognitive assessments and unobtrusive sensors are gaining traction for their potential to improve early detection and monitoring of cognitive impairment. Given the high prevalence of cognitive impairments in T2D, these digital tools are highly relevant. Further research incorporating remote digital biomarkers of cognition, behavior, and motor functioning may enable comprehensive characterizations of patients with T2D and may ultimately improve clinical care and equitable access to research participation. The aim of this commentary article is to review the feasibility, validity, and limitations of using remote digital cognitive tests and unobtrusive detection methods to identify and monitor cognitive decline in neurodegenerative conditions and apply these insights to patients with T2D.
引用
收藏
页码:1489 / 1499
页数:11
相关论文
共 50 条
  • [31] Urine haptoglobin levels predict early renal functional decline in patients with type 2 diabetes
    Bhensdadia, Nishant M.
    Hunt, Kelly J.
    Lopes-Virella, Maria F.
    Tucker, J. Michael
    Mataria, Mohammad R.
    Alge, Joseph L.
    Neely, Benjamin A.
    Janech, Michael G.
    Arthur, John M.
    KIDNEY INTERNATIONAL, 2013, 83 (06) : 1136 - 1143
  • [32] Decreased Plasma Level of Lipoprotein Lipase Predicted Verbal Disfluency in Chinese Type 2 Diabetes Mellitus Patients with Early Cognitive Deficits
    An, Ke
    Guo, Peng
    Zhang, Haoqiang
    Zhu, Wenwen
    Cao, Wuyou
    Shi, Jijing
    Wang, Shaohua
    CURRENT ALZHEIMER RESEARCH, 2021, 18 (08) : 656 - 666
  • [33] Assessment of remote patient monitoring (RPM) systems for patients with type 2 diabetes: a systematic review and meta-analysis
    Salehi, Sahar
    Olyaeemanesh, Alireza
    Mobinizadeh, Mohammadreza
    Nasli-Esfahani, Ensieh
    Riazi, Hossein
    JOURNAL OF DIABETES AND METABOLIC DISORDERS, 2020, 19 (01) : 115 - 127
  • [34] Predictive model for early detection of type 2 diabetes using patients' clinical symptoms, demographic features, and knowledge of diabetes
    Ojurongbe, Taiwo Adetola
    Afolabi, Habeeb Abiodun
    Oyekale, Adesola
    Bashiru, Kehinde Adekunle
    Ayelagbe, Olubunmi
    Ojurongbe, Olusola
    Abbasi, Saddam Akber
    Adegoke, Nurudeen A.
    HEALTH SCIENCE REPORTS, 2024, 7 (01)
  • [35] Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study
    Xu, Zhi-Peng
    Yang, Su-Lian
    Zhao, Shi
    Zheng, Cheng-Hong
    Li, Hong-Hua
    Zhang, Yao
    Huang, Rong-Xi
    Li, Meng-Zhu
    Gao, Yuan
    Zhang, Shu-Juan
    Zhan, Pei-Yan
    Zhang, Li-Fang
    Deng, Lin
    Wei, Sheng
    Liu, Yan-Chao
    Ye, Jing-Wang
    Ren, Hu-Jun
    Li, Na
    Kong, Cai-Xia
    Wang, Xin
    Fang, Lin
    Zhou, Qiu-Zhi
    Jiang, Hong-Wei
    Li, Jing-Rong
    Wang, Qun
    Ke, Dan
    Liu, Gong-Ping
    Wang, Jian-Zhi
    EBIOMEDICINE, 2016, 5 : 105 - 113
  • [36] Prevalence of Cognitive Decline in Type 2 Diabetes Mellitus Patients: A Real-World Cross-Sectional Study in Mysuru, India
    Kinattingal, Nabeel
    Mehdi, Seema
    Undela, Krishna
    Wani, Shahid Ud Din
    Almuqbil, Mansour
    Alshehri, Sultan
    Shakeel, Faiyaz
    Imam, Mohammad T.
    Manjula, Santhepete N.
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (03):
  • [37] Liraglutide Effectiveness in Type 2 Diabetes: Insights from a Real-World Cohort of Portuguese Patients
    Silva-Nunes, Jose
    Nascimento, Edite
    Louro, Joana
    Dores, Jorge
    Laginha, Teresa
    Goncalves-Ferreira, Ana
    Alves, Marta
    Souto, Selma B.
    Cunha, Nelson
    Pina, Elsa
    Duarte, Rui
    Raposo, Joao Filipe
    METABOLITES, 2022, 12 (11)
  • [38] Advances in the management of cardiovascular risk for patients with type 2 diabetes: perspectives from the Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes
    Schernthaner, Guntram
    Jarvis, Sarah
    Lotan, Chaim
    Prazny, Martin
    Wanner, Christoph
    Wascher, Thomas C.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 69 - 79
  • [39] The neural correlates of emotional conflict monitoring as an early manifestation of affective and cognitive declines in persons with Type 2 diabetes
    Chen, Yu-Hsin
    Chen, Chenyi
    Jian, Hong-Yu
    Chen, Yu-Chun
    Fan, Yang-Teng
    Yang, Chih-Yung
    Cheng, Yawei
    BRAIN COMMUNICATIONS, 2022, 5 (01)
  • [40] The Gaze Fixation Assessed by Microperimetry: A Useful Tool for the Monitoring of the Cognitive Function in Patients with Type 2 Diabetes
    Ortiz-Zuniga, Angel Michael
    Simo-Servat, Olga
    Rojano-Toimil, Alba
    Vazquez-de Sebastian, Julia
    Castellano-Tejedor, Carmina
    Hernandez, Cristina
    Simo, Rafael
    Ciudin, Andreea
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):